Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Atilio Navarro
Observed names:
A Navarro,
A. Navarro
Institution:
Hospital General Universitario De Valencia
Observed institutions:
Universidad de la República de Uruguay,
Aarhus University Hospital,
Institut Català d'Oncologia,
Hospital General Universitario De Valencia,
Universitat de Barcelona
ORCID:
0000-0002-1361-0954
Observed ORCID:
0000-0002-1361-0954
OpenAlex ID:
A5014194182
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
2017
·
Igor Letovanec
, Stephen Finn
, et al.
·
Journal of Thoracic Oncology
·
86
PDF
Oxidative stress‐induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages
2011
·
J. Milara
, A. Navarro
, et al.
·
Clinical & Experimental Allergy
·
59
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project
2019
·
Keith M. Kerr
, Erik Thunnissen
, et al.
·
Lung Cancer
·
48
PDF
Extra-nodal B-cell non-Hodgkin's lymphomas of the head and neck: A study of 68 cases
2014
·
Jose V. Bagan
, Felix Carbonell
, et al.
·
American Journal of Otolaryngology
·
34
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
2019
·
Erik Thunnissen
, Keith M. Kerr
, et al.
·
Modern Pathology
·
32
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort
2018
·
Undine Rulle
, Zoi Tsourti
, et al.
·
Journal of Thoracic Oncology
·
7
PDF
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer
2026
·
Teodora Radonic
, Sepehr Rahmani-Khajouei
, et al.
·
Lung Cancer
·
4
Stemness characterization of tumorspheres from non-small cell lung cancer: Differential expression in CSC-related markers and signaling pathways
2017
·
A. Herreros Pomares
, S. Calabuig Fariñas
, et al.
·
Annals of Oncology
·
2
P2.16F.02 LIFE Project: Lung Cancer Patients' Involvement in Research Fostering Their Empowerment
2024
·
B. Gaspar
, X.C. Bayona
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project
2024
·
Ernst-Jan M. Speel
, Urania Dafni
, et al.
·
Lung Cancer
·
1
PDF
1167P DIO2 is implicated in the antitumor effect of the lung embryonic stem cell conditioned medium and impacts prognosis in non-small cell lung cancer
2021
·
J. Canals
, A. Navarro
, et al.
·
Annals of Oncology
·
1
An expression signature characterizes cancer stem cells from lung adenocarcinoma patients
2018
·
A. Herreros-Pomares
, S. Calabuig Fariñas
, et al.
·
Annals of Oncology
·
1
21P Influence of delayed and prolonged fixation on the evaluation of immunohistochemical staining on pulmonary resection specimen
2018
·
M. Van Seijen
, L. Brcic
, et al.
·
Journal of Thoracic Oncology
·
1
Prevalence and clinical correlation of programmed cell death 1 ligand (PD-L1) expression in patients with resected non-small cell lung cancer (NSCLC): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort.
2017
·
Keith Kerr
, Erik Thunnissen
, et al.
·
Journal of Clinical Oncology
·
1
Prevalence and clinical associations of PTEN loss in non-small cell lung carcinoma (NSCLC) patients (pts) of the European Thoracic Oncology Platform (ETOP) Lungscape cohort
2016
·
A. Soltermann
, U. Rulle
, et al.
·
Annals of Oncology
·
1
Differential expression of tumorspheres in CSC-markers and signaling pathways from non-small cell lung cancer.
2016
·
Alejandro Herreros-Pomares
, Ester Munera-Maravilla
, et al.
·
Journal of Clinical Oncology
·
1
miR-34a as a prognostic marker of relapse in non-small-cell lung cancer (NSCLC) patients (p)after curative surgery
2008
·
E. Gallardo
, A. Navarro
, et al.
·
Journal of Clinical Oncology
·
1
Paraganglioma maligno nasosinusal: un gran desafío clínico e histopatológico en una entidad infrecuente
2025
·
A. Ángel-de-Miguel
, A. Navarro
, et al.
·
Acta Otorrinolaringológica Española
367P: Clinical characteristics and ctDNA as prognostic tools in KRAS-mutated NSCLC during first line treatment (1L)
2025
·
P. Espinosa-Olarte
, E. Munera Maravilla
, et al.
·
Journal of Thoracic Oncology
PDF
Lung tumorspheres as a drug screening platform against cancer stem cells
2019
·
A. Herreros Pomares
, H. Amado
, et al.
·
Annals of Oncology
PDF
Complete Response to Chemotherapy in A Patient with Unresectable Extrahepatic Cholangiocarcinoma
2019
·
Ihsan Shaheen
, Miriam Lobo
, et al.
·
Archives of Clinical and Medical Case Reports
P05.21 T1-flair to T1-gadolinium MRI ratio as a predictive value of treatment response in non-small-cell lung cancer (NSCLC) patients affected by multiple brain metastases
2018
·
M Alemany
, M Domènech
, et al.
·
Neuro-Oncology
PDF
Association of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort
2017
·
K.M. Kerr
, E. Thunnissen
, et al.
·
Annals of Oncology
PDF
Abstract 4424: Cancer stem cells-related microRNAs have prognostic implications in non-small cell lung cancer
2017
·
Sandra Gallach Garcia
, Alejandro Herreros-Pomares
, et al.
·
Cancer Research
P1.02-025 Evaluation of NGS and RT-PCR Methods for ALK Assessment in European NSCLC Patients: Results from the ETOP Lungscape Project
2017
·
Stephen Finn
, Igor Letovanec
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
27
Citation count:
313
H-index:
7
I10-index:
6
Year
Topic
Type